Activities pefloxacin ciprofloxacin experimental malaria mice vivo antimalarial activities pefloxacin ciprofloxacin Swiss albino mice Plasmodium yoelii treatment Groups mice subcutaneous injection mg ciprofloxacin pefloxacin kg body weight days Parasitologic activity day survival day Control mice fulminant course parasitemia day mice dead day dosages pefloxacin ciprofloxacin mg/kg efficient mg/kg ciprofloxacin reduction parasitemia mice Pefloxacin reduction parasitemia mice control mice ciprofloxacin antimalarial activity similar injections mg/kg injections mg/kg pefloxacin similar activities injections mg/kg injections mg/kg drugs activity treatment need treatment first hours infection optimal effect lethal experimental model malaria Pefloxacin extent ciprofloxacin potent antimalarial drugs useful treatment aggressive human malaria 